These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33035354)

  • 1. Use of the wearable cardioverter-defibrillator - the Swiss experience.
    Kovacs B; Reek S; Sticherling C; Schaer B; Linka A; Ammann P; Brenner R; Krasniqi N; Müller AS; Dzemali O; Kobza R; Grebmer C; Haegeli L; Berg J; Mayer K; Schläpfer J; Domenichini G; Reichlin T; Roten L; Burri H; Eriksson U; Saguner AM; Steffel J; Duru F; Swiss Wcd Registry
    Swiss Med Wkly; 2020 Sep; 150():w20343. PubMed ID: 33035354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B; Reek S; Saguner AM; Krasniqi N; Eriksson U; Duru F
    Swiss Med Wkly; 2019 Nov; 149():w20136. PubMed ID: 31707723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry.
    El-Battrawy I; Tenbrink D; Kovacs B; Dreher TC; Blockhaus C; Klein N; Shin DI; Hijazi M; Rosenkaimer S; Beiert T; Abumayyaleh M; Saguner AM; Kowitz J; Erath JW; Duru F; Mügge A; Aweimer A; Akin I
    Eur J Clin Invest; 2023 Jul; 53(7):e13977. PubMed ID: 36852491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM; Bense J; Hohenforst-Schmidt W
    J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.
    Singh M; Wang NC; Jain S; Voigt AH; Saba S; Adelstein EC
    J Am Coll Cardiol; 2015 Dec; 66(23):2607-2613. PubMed ID: 26670060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R; Combes N; Defaye P; Narayanan K; Guedon-Moreau L; Boveda S; Blangy H; Bouet J; Briand F; Chevalier P; Cottin Y; Da Costa A; Degand B; Deharo JC; Eschalier R; Extramiana F; Goralski M; Guy-Moyat B; Guyomar Y; Hermida JS; Jourda F; Lellouche N; Mahfoud M; Manenti V; Mansourati J; Martin A; Pasquié JL; Ritter P; Rollin A; Tibi T; Yalioua A; Gras D; Sadoul N; Piot O; Leclercq C; Marijon E
    Europace; 2021 Jan; 23(1):73-81. PubMed ID: 33257972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry.
    El-Battrawy I; Kovacs B; Dreher TC; Klein N; Rosenkaimer S; Röger S; Kuschyk J; Saguner AM; Kowitz J; Erath JW; Duru F; Akin I
    Sci Rep; 2022 Feb; 12(1):3203. PubMed ID: 35217697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    Clin Cardiol; 2017 Aug; 40(8):586-590. PubMed ID: 28333373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O
    J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
    Kuehn C; Ruemke S; Rellecke P; Lichtenberg A; Joskowiak D; Hagl C; Hassan M; Leyh RG; Erler S; Garbade J; Eifert S; Grieshaber P; Boening A; Doenst T; Velichkov I; Madej T; Knaut M; Hain A; Burger H
    Eur J Cardiothorac Surg; 2022 May; 61(5):1031-1040. PubMed ID: 35174386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience With Wearable Cardioverter-Defibrillators at 2 Academic Medical Centers.
    Leyton-Mange JS; Hucker WJ; Mihatov N; Reynolds M; Albert C; Lubitz SA; Milan DJ
    JACC Clin Electrophysiol; 2018 Feb; 4(2):231-239. PubMed ID: 29749943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death.
    Kutyifa V; Vermilye K; Daimee UA; McNitt S; Klein H; Moss AJ
    Europace; 2018 Sep; 20(FI2):f225-f232. PubMed ID: 29905788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M; Weyand M; Seitz T; Harig F
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A wearable cardioverter defibrillator with a low false alarm rate.
    Poole JE; Gleva MJ; Birgersdotter-Green U; Branch KRH; Doshi RN; Salam T; Crawford TC; Willcox ME; Sridhar AM; Mikdadi G; Beinart SC; Cha YM; Russo AM; Rowbotham RK; Sullivan J; Gustavson LM; Kivilaid K
    J Cardiovasc Electrophysiol; 2022 May; 33(5):831-842. PubMed ID: 35174572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET; Williams S; Cronin EM; Blackstone EH; Ellis SG; Roselli EE; Smedira NG; Gillinov AM; Glad JA; Tchou PJ; Szymkiewicz SJ; Chung MK
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):117-28. PubMed ID: 23275233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.